Publication | Open Access

Discovery of novel 1,3,5-triazine derivatives as potent inhibitor of cervical cancer via dual inhibition of PI3K/mTOR

Medicinal ChemistryCervical CancerDual InhibitionMedicinePharmacological AgentNovel 1,3,5-Triazine DerivativesPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyPharmaceutical ChemistryDrug Discovery